Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides

Biochemistry

Volumn 47, Issue 24, 2008, Pages 6468-6478

  Rosenfeld, Yosef ^a   Sahl, Hans Georg ^b   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; AMINO ACIDS; BACTERIA; BACTERIOLOGY; COMPUTER NETWORKS; DETOXIFICATION; ORGANIC ACIDS; PEPTIDES; POLYSACCHARIDES; PROTEINS; STRUCTURE (COMPOSITION);

(PL) PROPERTIES; AMINO ACID COMPOSITIONS; ANTIMICROBIAL PEPTIDE (AMP); GRAM-NEGATIVE BACTERIA; INNATE IMMUNE SYSTEMS; LIPOPOLYSACCHARIDE (LPS); OUTER MEMBRANES; PROTECTIVE BARRIERS;

HEALTH;

ENDOTOXIN; LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DETOXIFICATION; DIASTEREOISOMER; ENZYME ACTIVITY; FLUORESCENCE SPECTROSCOPY; HOST RESISTANCE; INFRARED SPECTROSCOPY; INNATE IMMUNITY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CANDIDA ALBICANS; CELL LINE; DRUG RESISTANCE, BACTERIAL; HUMANS; LIPOPOLYSACCHARIDES; METABOLIC DETOXICATION, DRUG; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING;

NEGIBACTERIA;

EID: 45749084085     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800450f     Document Type: Article

References (53)

1. Nikaido, H. (1994) Prevention of drug access to bacterial targets: Permeability barriers and active efflux. Science 264, 382-388.
2. Snyder, D. S., and McIntosh, T. J. (2000) The lipopolysaccharide barrier: Correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. Biochemistry 39, 11777-11787.
3. Nikaido, H., and Vaara, M. (1985) Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49, 1-32.
4. Hancock, R. E. (1984) Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38, 237-264.
5. Ginsburg, I. (2002) The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae. APMIS 110, 753-770.
6. Ulevitch, R. J., and Tobias, P. S. (1999) Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11, 19-22.
7. Tobias, P. S., Soldau, K., and Ulevitch, R. J. (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164, 777-793.
8. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., VanHuffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088.
9. Zhang, F. X., Kirschning, C. J., Mancinelli, R., Xu, X. P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., and Arditi, M. (1999) Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274, 7611-7614.
10. Cohen, J. (2002) The immunopathogenesis of sepsis. Nature 420, 885-891.
11. Boman, H. G. (1995) Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13, 61-92.
12. Jerala, R., and Porro, M. (2004) Endotoxin neutralizing peptides. Curr. Top. Med. Chem. 4, 1173-1184.
13. Hancock, R. E., and Scott, M. G. (2000) The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U.S.A. 97, 8856-8861.
14. Rosenfeld, Y., Papo, N., and Shai, Y. (2006) Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides: Peptide Properties and Plausible Modes of Action. J. Biol. Chem. 281, 1636-1643.
15. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
16. Scott, M. G., Rosenberger, C. M., Gold, M. R., Finlay, B. B., and Hancock, R. E. (2000) An α-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J. Immunol. 165, 3358-3365.
17. Andra, J., Koch, M. H., Bartels, R., and Brandenburg, K. (2004) Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin. Antimicrob. Agents Chemother. 48, 1593-1599.
18. Motobu, M., Amer, S., Yamada, M., Nakamura, K., Saido-Sakanaka, H., Asaoka, A., Yamakawa, M., and Hirota, Y. (2004) Effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on mouse peritoneal macrophages stimulated with lipopolysaccharide. J. Vet. Med. Sci. 66, 319-322.
19. Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., and Wright, S. C. (1995) Human CAP18: A novel antimicrobial lipopolysaccharide- binding protein. Infect. Immun. 63, 1291-1297.
20. Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Orlando, F., Silvestri, C., Bozzi, A., Di Giulio, A., Luzi, C., Mangoni, M. L., Barra, D., Saba, V., Scalise, G., and Rinaldi, A. C. (2006) Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob. Agents Chemother. 50, 2478-2486.
21. Brown, K. L., and Hancock, R. E. (2005) Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18, 24-30.
22. Castano, S., Cornut, I., Buttner, K., Dasseux, J. L., and Dufourcq, J. (1999) The amphipathic helix concept: Length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. Biochim. Biophys. Acta 1416, 161-175.
23. Beven, L., Castano, S., Dufourcq, J., Wieslander, A., and Wroblewski, H. (2003) The antibiotic activity of cationic linear amphipathic peptides: Lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. Eur. J. Biochem. 270, 2207-2217.
24. Pouny, Y., and Shai, Y. (1992) Interaction of D-amino acid incorporated analogues of pardaxin with membranes. Biochemistry 31, 9482-9490.
25. Rapaport, D., and Shai, Y. (1991) Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J. Biol. Chem. 266, 23769-23775.
26. de Haas, C. J., van Leeuwen, H. J., Verhoef, J., van Kessel, K. P., and van Strijp, J. A. (2000) Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS. J. Immunol. Methods 242, 79-89.
27. Oren, Z., and Shai, Y. (2000) Cyclization of a cytolytic amphipathic α-helical peptide and its diastereomer: Effect on structure, interaction with model membranes, and biological function. Biochemistry 39, 6103-6114.
28. Tamm, L. K., and Tatulian, S. A. (1997) Infrared spectroscopy of proteins and peptides in lipid bilayers. Q. Rev. Biophys. 30, 365-429.
29. Greenfield, N., and Fasman, G. D. (1969) Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8, 4108-4116.
30. Wu, C. S., Ikeda, K., and Yang, J. T. (1981) Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry 20, 566-670.
31. Meng, F. G., Zeng, X., Hong, Y. K., and Zhou, H. M. (2001) Dissociation and unfolding of GCN4 leucine zipper in the presence of sodium dodecyl sulfate. Biochimie 83, 953-956.
32. Opal, S. M., Scannon, P. J., Vincent, J. L., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., and Lemke, J. H. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180, 1584-1589.
33. Frey, S., and Tamm, L. K. (1990) Membrane insertion and lateral diffusion of fluorescence-labelled cytochrome c oxidase subunit IV signal peptide in charged and uncharged phospholipid bilayers. Biochem. J. 272, 713-719.
34. Gutsmann, T., Fix, M., Larrick, J. W., and Wiese, A. (2000) Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids. J. Membr. Biol. 176, 223-236.
35. Papo, N., and Shai, Y. (2005) A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. J. Biol. Chem. 280, 10378-10387.
36. Avrahami, D., and Shai, Y. (2002) Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry 41, 2254-2263.
37. Avrahami, D., and Shai, Y. (2004) A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J. Biol. Chem. 279, 12277-12285.
38. Jackson, M., and Mantsch, H. H. (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30, 95-120.
39. Frey, S., and Tamm, L. K. (1991) Orientation of melittin in phospholipid bilayers. A polarized attenuated total reflection infrared study. Biophys. J. 60, 922-930.
40. Oren, Z., Lerman, J. C., Gudmundsson, G. H., Agerberth, B., and Shai, Y. (1999) Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes:Relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341, 501-513.
41. Sharon, M., Oren, Z., Shai, Y., and Anglister, J. (1999) 2D-NMR and ATR-FTIR study of the structure of a cell-selective diastereomer of melittin and its orientation in phospholipids. Biochemistry 38, 15305-15316.
42. Papo, N., Oren, Z., Pag, U., Sahl, H. G., and Shai, Y. (2002) The consequence of sequence alteration of an amphipathic α-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 277, 33913-33921.
43. Bowdish, D. M., and Hancock, R. E. (2005) Anti-endotoxin properties of cationic host defence peptides and proteins. J. Endotoxin Res. 11, 230-236.
44. Merrifield, R. B., Merrifield, E. L., Juvvadi, P., Andreu, D., and Boman, H. G. (1994) Design and synthesis of antimicrobial peptides. Ciba Found. Symp. 186, 5-26.
45. Oren, Z., and Shai, Y. (1998) Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47, 451-463.
46. Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462, 55-70.
47. Falla, T. J., Karunaratne, D. N., and Hancock, R. E. (1996) Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271, 19298-19303.
48. Matsuzaki, K., Harada, M., Funakoshi, S., Fujii, N., and Miyajima, K. (1991) Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim. Biophys. Acta 1063, 162-170.
49. Chen, X., Howe, J., Andra, J., Rossle, M., Richter, W., da Silva, A. P., Krensky, A. M., Clayberger, C., and Brandenburg, K. (2007) Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins. Biochim. Biophys. Acta 1768, 2421-2431.
50. Shnyra, A., Hultenby, K., and Lindberg, A. A. (1993) Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect. Immun. 61, 5351-5360.
51. Andra, J., Lamata, M., Martinez de Tejada, G., Bartels, R., Koch, M. H., and Brandenburg, K. (2004) Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Biochem. Pharmacol. 68, 1297-1307.
52. Howe, J., Andra, J., Conde, R., Iriarte, M., Garidel, P., Koch, M. H., Gutsmann, T., Moriyon, I., and Brandenburg, K. (2007) Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B. Biophys. J. 92, 2796-2805.
53. Andra, J., Howe, J., Garidel, P., Rossle, M., Richter, W., Leiva-Leon, J., Moriyon, I., Bartels, R., Gutsmann, T., and Brandenburg, K. (2007) Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: Thermodynamic, biophysical and microbiological analysis. Biochem. J. 406, 297-307.